Tranilast prevents doxorubicin-induced myocardial hypertrophy and angiotensin II synthesis in rats
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tranilast prevents doxorubicin-induced myocardial hypertrophy and angiotensin II synthesis in rats
Authors
Keywords
Tranilast, Doxorubicin, Angiotensin II, Chymase, Myocardial hypertrophy
Journal
LIFE SCIENCES
Volume 267, Issue -, Pages 118984
Publisher
Elsevier BV
Online
2020-12-29
DOI
10.1016/j.lfs.2020.118984
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cardioprotective effects of dapsone against doxorubicin-induced cardiotoxicity in rats
- (2020) Mohammad Sheibani et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Doxorubicin‑induced oxidative and nitrosative stress: Mitochondrial connexin 43 is at the crossroads
- (2020) Michela Pecoraro et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Salidroside Attenuates Doxorubicin-Induced Cardiac Dysfunction Partially Through Activation of QKI/FoxO1 Pathway
- (2020) Fangying Yan et al. Journal of Cardiovascular Translational Research
- Tranilast Directly Targets NLRP3 to Protect Melanocytes From Keratinocyte-Derived IL-1β Under Oxidative Stress
- (2020) Tongtian Zhuang et al. Frontiers in Cell and Developmental Biology
- MicroRNA-128-3p aggravates doxorubicin-induced liver injury by promoting oxidative stress via targeting Sirtuin-1
- (2019) Xuerong Zhao et al. PHARMACOLOGICAL RESEARCH
- ST2/IL-33 signaling in cardiac fibrosis
- (2019) Elena Vianello et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Rotenone and 3-bromopyruvate toxicity impacts electrical and structural cardiac remodeling in rats
- (2019) Chengchuang Zhan et al. TOXICOLOGY LETTERS
- Molecular mechanism of doxorubicin-induced cardiomyopathy – An update
- (2018) Kaviyarasi Renu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Recent progress in doxorubicin-induced cardiotoxicity and protective potential of natural products
- (2018) Jie Yu et al. PHYTOMEDICINE
- Chymase inhibitors for the treatment of cardiac diseases: a patent review (2010–2018)
- (2018) Sarfaraz Ahmad et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Prolonged QTc indicates the clinical severity and poor prognosis in patients with isolated left ventricular non-compaction
- (2017) Hongmei Zhou et al. INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING
- Role of connexin 43 in different forms of intercellular communication – gap junctions, extracellular vesicles and tunnelling nanotubes
- (2017) Teresa M. Ribeiro-Rodrigues et al. JOURNAL OF CELL SCIENCE
- LCZ696 improves cardiac function via alleviating Drp1-mediated mitochondrial dysfunction in mice with doxorubicin-induced dilated cardiomyopathy
- (2017) Yan Xia et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- TGF-β1 Signaling and Tissue Fibrosis
- (2017) Kevin K. Kim et al. Cold Spring Harbor Perspectives in Biology
- Anti-Allergic Drugs Tranilast and Ketotifen Dose-Dependently Exert Mast Cell-Stabilizing Properties
- (2016) Asuka Baba et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- The Biological Basis for Cardiac Repair After Myocardial Infarction
- (2016) Sumanth D. Prabhu et al. CIRCULATION RESEARCH
- Cross-Talk between Human Mast Cells and Bronchial Epithelial Cells in Plasminogen Activator Inhibitor-1 Production via Transforming Growth Factor-β1
- (2015) Seong H. Cho et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Tranilast reduces serum IL-6 and IL-13 and protects against thioacetamide-induced acute liver injury and hepatic encephalopathy
- (2015) Rania R. Abdelaziz et al. ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
- Tranilast: A review of its therapeutic applications
- (2015) Sara Darakhshan et al. PHARMACOLOGICAL RESEARCH
- Cardiotoxicity in rabbits after a low-level exposure to diazinon, propoxur, and chlorpyrifos
- (2014) A Zafiropoulos et al. HUMAN & EXPERIMENTAL TOXICOLOGY
- Protection against Ovariectomy-Induced Bone Loss by Tranilast
- (2014) Tien Van Phan et al. PLoS One
- The pathogenesis of cardiac fibrosis
- (2013) Ping Kong et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Doxorubicin-induced death in tumour cells and cardiomyocytes: is autophagy the key to improving future clinical outcomes?
- (2013) Oktay Tacar et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Doxorubicin-Induced Cardiotoxicity: From Bioenergetic Failure and Cell Death to Cardiomyopathy
- (2013) Filipa S. Carvalho et al. MEDICINAL RESEARCH REVIEWS
- Short-term ACE inhibition confers long-term protection against target organ damage
- (2012) Taben M Hale et al. HYPERTENSION RESEARCH
- Tranilast Prevents Atrial Remodeling and Development of Atrial Fibrillation in a Canine Model of Atrial Tachycardia and Left Ventricular Dysfunction
- (2012) Yosuke Nakatani et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Potential Therapeutic Targets for Cardiac Fibrosis
- (2010) Andrew Leask CIRCULATION RESEARCH
- Tranilast attenuates the up-regulation of thioredoxin-interacting protein and oxidative stress in an experimental model of diabetic nephropathy
- (2010) S. M. Tan et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Protective effect of tetrahydroxystilbene glucoside on cardiotoxicity induced by doxorubicin in vitro and in vivo
- (2009) Shao-hui Zhang et al. ACTA PHARMACOLOGICA SINICA
- Doxorubicin: The Good, the Bad and the Ugly Effect
- (2009) Cristina Carvalho et al. CURRENT MEDICINAL CHEMISTRY
- Tranilast, an orally active anti-allergic drug, up-regulates the anti-inflammatory heme oxygenase-1 expression but down-regulates the pro-inflammatory cyclooxygenase-2 and inducible nitric oxide synthase expression in RAW264.7 macrophages
- (2008) Hyun-Ock Pae et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now